Therapeutic innovation in adult-onset Still's disease (and other rare inflammatory disorders): how to secure evidence-based medicine?

Ann Rheum Dis. 2018 Dec;77(12):1699-1701. doi: 10.1136/annrheumdis-2018-213106. Epub 2018 Jun 2.

Authors

Philippe Guilpain^{1

2

3}, Alain Le Quellec^{1

2}, Alexandre Thibault Jacques Maria^{1

2

3}

Affiliations

¹ Medical School, Montpellier University, Montpellier, France.
² Department of Internal Medicine - Multi-Organic Diseases, Local Referral Center for Autoimmune Diseases, University of Montpellier, Saint-Eloi Hospital, Montpellier, France.
³ Institute for Regenerative Medicine and Biotherapy (IRMB), Inserm, U1183, Saint-Eloi Hospital, Montpellier, France.

PMID: 29860231
DOI: 10.1136/annrheumdis-2018-213106

No abstract available

Keywords: adult onset still’s disease; inflammation; treatment.

Publication types

Editorial
Comment

MeSH terms

Adult
Evidence-Based Medicine
Humans
Rare Diseases
Still's Disease, Adult-Onset*